Drugs / OncoImmunome
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02933073 | Nov 2016 → Aug 2022 | ovarian carcinoma | UConn Health | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OncoImmunome | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02933073 ↗ |
| Modality | Vaccine | “OncoImmunome vaccine” NCT02933073 ↗ |